James Napier

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

The nitrogen hyperfine splitting constant of the nitroxide functional group as a solvent polarity parameter. The relative importance for a solvent polarity parameter of its being a cybotactic probe vs. its being a model process

Bruce R. Knauer, James Napier · Journal of the American Chemical Society · 1976 · 274 citations

Natural Sciences, Chemistry, Organic Chemistry +11

(−)-Spiro[1-azabicyclo[2.2.2]octane-3,5‘-oxazolidin-2‘-one], a Conformationally Restricted Analogue of Acetylcholine, Is a Highly Selective Full Agonist at the α7 Nicotinic Acetylcholine Receptor

G. B. MULLEN, James Napier, Michael Balestra et al. · Journal of Medicinal Chemistry · 2000 · 132 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

An enantioselective and highly convergent synthesis of (+)-ikarugamycin

Robert K. Boeckman, Charles H. Weidner, Robert B. Perni et al. · Journal of the American Chemical Society · 1989 · 92 citations

Natural Sciences, Chemistry, Medicinal Chemistry +6

Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide

Gene C. Palmer, Robert Murray, Theresa C. Wilson et al. · Epilepsy Research · 1992 · 81 citations

Medicine, Medicinal Chemistry, Pharmacology +10